2026 жылында Польшада фокусталған ультрадыбыстық абляцияға (HIFU) бойынша ең жақсы бағалар мен клиникалар туралы біліңіз

HIFU is approved and regulated in Poland for treating localized prostate cancer. It is a safe, minimally invasive procedure adhering to European Union Medical Device Regulation. Specialized centers like Carolina Hospital and European Health Center Otwock utilize robotic systems like Focal-One to provide targeted cancer therapy.

• Regulatory compliance: HIFU systems must satisfy strict European Union Medical Device Regulation (MDR) safety standards.
• Expert certifications: Surgeons like Dr. Marek Filipek are European Board of Urology (FEBU) certified specialists.
• Advanced technology: Clinics utilize Focal-One and Ablatherm devices for precise, robotic-assisted tumor tissue destruction.
• Clinical oversight: Facilities maintain ISO 9001:2015 quality management systems and Polish Ministry of Health registration.

Bookimed Expert Insight: Poland serves as a primary training hub for this technology. Dr. Marek Filipek at Carolina Hospital is the only specialist in Central Europe authorized to train other medical teams in the HIFU method. This concentration of teaching expertise suggests a higher standard of technical proficiency than typically found in general urology departments.

Patient Consensus: Patients value this method specifically for its lower impact on quality of life. Reported rates for side effects like incontinence remain under 10%, which is significantly lower than traditional radical surgery.

Focal HIFU for prostate cancer in Poland delivers 100% cancer-specific survival and 99% overall survival at 5 years. Patients can expect 88% overall failure-free survival, though results vary by risk level. Intermediate-risk cases typically reach 85% retreatment-free status during this timeframe within JCI or ISO-accredited facilities.

• Survival rates: 5-year metastasis-free survival reached 98% in clinical studies for focal therapy.
• Treatment failure: Approximately 20% to 30% of patients require secondary treatment within 5 years.
• Success markers: PSA nadir typically occurs within 3 to 6 months after treatment.
• Follow-up protocol: Polish centers require PSA testing every 3 months and annual MRI scans.

Bookimed Expert Insight: Poland offers a unique advantage for HIFU through surgeons like Dr. Marek Filipek at Carolina Hospital, the first Polish urologist certified as an Ablatherm HIFU operator. Expert data suggests that choosing a trainer who teaches other medical teams minimizes technical recurrence risks typically seen in the first 14% to 37% of cases.

Patient Consensus: Patients emphasize that tracking PSA doubling time is more critical than the absolute number. Many recommend confirming unifocal disease via mpMRI before choosing HIFU to avoid out-of-field recurrence in untreated areas.

HIFU in Poland is a non-surgical procedure allowing patients to fly home within 1 to 3 days. Most individuals resume light activities in 1 to 2 weeks. Full recovery typically occurs within 4 to 6 weeks depending on the treatment area and individual healing.

• Hospital stay: Patients are usually discharged the same day or the following morning.
• Flight readiness: International travel is feasible 24 to 48 hours post-procedure after confirming no edema.
• Work resumption: Office-based tasks are possible within 3 days without the need for pain medication.
• Physical activity: Active individuals can safely return to gym routines within 3 to 4 weeks.

Bookimed Expert Insight: Poland offers unique access to some of the world's most experienced HIFU practitioners. Dr. Marek Filipek at Carolina Hospital is the only doctor in Central and Eastern Europe who trains medical teams in this specific method. Choosing a training center ensures you receive care based on the latest clinical safety protocols and most precise focal therapy techniques.

Patient Consensus: Patients find recovery remarkably swift, often returning to desk jobs within three days. Many highlight that drinking 4 liters of water daily significantly reduces post-procedure swelling and speeds up the return to normal life.

Ideal candidates for HIFU in Poland are men with localized, low-to-intermediate risk prostate cancer, typically with Gleason scores of 6 or 7. Patients must have a prostate volume under 50cc to ensure complete ablation, primarily using advanced technologies like Ablatherm or Focal-One.

• Imaging requirements: Multiparametric MRI (mpMRI) must confirm small, unilateral lesions within 6 months.
• Biopsy standards: A 12-core biopsy or fusion biopsy identifies tumor location and grade.
• Prostate metrics: PSA levels and precise volume assessment are required to prevent incomplete treatment.
• Health screening: Patients need a 6-week pre-op urine culture to rule out active infections.

Bookimed Expert Insight: While many centers set 50cc as a strict limit for HIFU, expertise matters significantly. Dr. Marek Filipek at Carolina Hospital is the only trainer for this method in Central Europe. His experience allows for more precise focal therapy, targeting only the lesion rather than the entire gland, which better preserves urinary and sexual function.

Patient Consensus: Men emphasize that prostate size is the most common reason for disqualification. Many suggest clearing any infections early, as a positive urine culture can lead to last-minute cancellations.

High intensity focused ultrasound ablation (HIFU) in Poland typically causes mild, manageable side effects since it is a non-invasive procedure. Temporary urinary frequency, slight perineal discomfort, or erectile changes are common. Most patients recover fully within 6 to 12 months using conservative management strategies.

• Urinary function: Symptoms resolve in weeks with pelvic floor exercises and tamsulosin.
• Perineal comfort: Mild swelling or pain is managed using ice packs and ibuprofen.
• Sexual health: Temporary erectile changes are treated with medication or vacuum pump therapy.
• Long-term monitoring: Doctors track PSA levels monthly with typical stabilization at 3–6 months.

Bookimed Expert Insight: While many facilities offer basic focal therapy, choosing a center like Carolina Hospital in Warsaw provides access to unique expertise. Dr. Marek Filipek was the first Polish urologist certified in Ablatherm HIFU and now trains other medical teams. This high volume of specialized training often leads to more precise targeting, which directly correlates with lower rates of long-term urinary complications.

Patient Consensus: Many patients notice immediate urinary changes but report that 80–90% of these side effects vanish within one year. Starting pelvic floor therapy immediately after the procedure is highly recommended for faster recovery.

Key hospitals in Poland performing MRI-guided HIFU include Carolina Hospital in Warsaw and European Health Center Otwock. Certified operators like Dr. Marek Filipek and Dr. Stefan Czarniecki utilize advanced Focal One and Ablatherm systems to treat prostate cancer and uterine fibroids with high precision.

• Top clinic: Carolina Hospital in Warsaw is a primary site for robotic HIFU treatments.
• Lead operator: Dr. Marek Filipek was the first Polish urologist certified for Ablatherm HIFU.
• Clinical expert: Dr. Stefan Czarniecki manages the specialized diagnostic and robotic prostate treatment center.
• Advanced technology: Facilities typically use MRI-integrated systems like Philips Sonalleve or robotic Focal One.

Bookimed Expert Insight: While many facilities perform ultrasound-guided HIFU, only a few specialize in true MRI fusion. Dr. Marek Filipek at Carolina Hospital is unique because he trains other European medical teams in these techniques. Patients should prioritize clinics like this where the surgeons are also international instructors to ensure the highest safety standards.

Patient Consensus: Patients often find that MRI-guided HIFU is a specialized service rarely covered by public insurance. Many recommend verifying a surgeon's specific manufacturer-certified training before booking, as expertise with the software is vital for success.

High intensity focused ultrasound ablation (HIFU) in Poland typically results in zero visible scars because it is a non-invasive procedure. Unlike traditional surgery, HIFU uses concentrated ultrasound energy delivered via transrectal probe or external application to treat tissue without any skin incisions or cuts.

• Incision type: No external incisions are required for either transrectal or external HIFU.
• Skin appearance: Temporary redness or minor swelling may occur but usually fades within days.
• Treatment delivery: Surgeons like Dr. Marek Filipek at Carolina Hospital use specialized internal probes.
• Aesthetic outcome: Patients maintain their natural skin appearance without permanent surgical marks or keloids.

Bookimed Expert Insight: While HIFU is fundamentally scarless, the choice of technology impacts your recovery experience. Centers like Carolina Hospital offer the Focal-One system, which allows for robotic precision in mapping. This advanced focal therapy often means shorter treatment times and less post-operative swelling compared to standard ablative methods.

Patient Consensus: Patients frequently choose HIFU specifically to avoid surgical scars. Many report the skin returns to normal almost immediately, with no visible evidence of an operation left behind.